Question 1

What are the potential benefits of participating in this trial for my child?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) clinical trial (NCT06191315). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I be aware of with dupilumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) clinical trial (NCT06191315). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will my child need to come in for visits during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) clinical trial (NCT06191315). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if my child experiences worsening asthma symptoms during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) clinical trial (NCT06191315). Contact the study team or your healthcare provider for specific answers.

Question 5

Can my child continue their current asthma medications while in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) clinical trial (NCT06191315). Contact the study team or your healthcare provider for specific answers.

Question 6

What is the difference between the treatment and the placebo in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) clinical trial (NCT06191315). Contact the study team or your healthcare provider for specific answers.

Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

What this study is about

Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

What this study is about